(Q38262690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

review article

1 reference

title

Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

21 February 2020

main subject

0 references

author

Sandra Amor

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Andrea Malaspina

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Fabiola Puentes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

25 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

published in

International Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

117-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344935%20AND%20SRC:MED&resulttype=core&format=json

How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

A proposed staging system for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Dissection of genetic factors associated with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Biomarkers in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Inflammation in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Inflammation in neurodegenerative diseases--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Redox regulation in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Inflammatory processes in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Class A scavenger receptor promotes cerebral ischemic injury by pivoting microglia/macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Oxidative stress in ALS: key role in motor neuron injury and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Heat shock proteins and protection of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Immunology. Dangers in and out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Microglia and neuroinflammation: a pathological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Disease-associated amyloid and misfolded protein aggregates activate the inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

The role of nitric oxide in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Extracellular mutant SOD1 induces microglial-mediated motoneuron injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

The complement factor C5a receptor is upregulated in NFL-/- mouse motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Role for terminal complement activation in amyotrophic lateral sclerosis disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Microglia in ALS: the good, the bad, and the resting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Autoimmunity in amyotrophic lateral sclerosis: past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Physiological characterization of human muscle acetylcholine receptors from ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Advances in the application of MRI to amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Amyotrophic lateral sclerosis-immunoglobulins selectively interact with neuromuscular junctions expressing P/Q-type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Vascular autoantibodies in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Treadmill exercise promotes interleukin 15 expression in skeletal muscle and interleukin 15 receptor alpha expression in adipose tissue of high-fat diet rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

THIS ARTICLE HAS BEEN RETRACTED Exercise induces interleukin-8 expression in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

TNF and sTNFR1/2 plasma levels in ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Plasma biomarkers associated with ALS and their relationship to iron homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Increased intrathecal high-avidity anti-tau antibodies in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Low avidity and level of serum anti-Abeta antibodies in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Unraveling the mechanisms involved in motor neuron degeneration in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Onset and progression in inherited ALS determined by motor neurons and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Towards a neuroimaging biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099

ALS: Cytokine profile in cerebrospinal fluid T‐cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU099